Back to User profile » Prof. Dr. Jingliang Wu

Papers published by Prof. Dr. Jingliang Wu:


GA&HA-Modified Liposomes for Co-Delivery of Aprepitant and Curcumin to Inhibit Drug-Resistance and Metastasis of Hepatocellular Carcinoma [Corrigendum]

Li Y, Wu J, Lu Q, Liu X, Wen J, Qi X, Liu J, Lian B, Zhang B, Sun H, Tian G

International Journal of Nanomedicine 2022, 17:3073-3074

Published Date: 12 July 2022

GA&HA-Modified Liposomes for Co-Delivery of Aprepitant and Curcumin to Inhibit Drug-Resistance and Metastasis of Hepatocellular Carcinoma

Li Y, Wu J, Lu Q, Liu X, Wen J, Qi X, Liu J, Lian B, Zhang B, Sun H, Tian G

International Journal of Nanomedicine 2022, 17:2559-2575

Published Date: 7 June 2022

Dual-Ligand-Modified Liposomes Co-Loaded with Anti-Angiogenic and Chemotherapeutic Drugs for Inhibiting Tumor Angiogenesis and Metastasis

Wang F, Li Y, Jiang H, Li C, Li Z, Qi C, Li Z, Gao Z, Zhang B, Wu J

International Journal of Nanomedicine 2021, 16:4001-4016

Published Date: 9 June 2021

Galactose Modified Liposomes for Effective Co-Delivery of Doxorubicin and Combretastatin A4

Lian B, Wei H, Pan R, Sun J, Zhang B, Wu J, Li X, Tian G

International Journal of Nanomedicine 2021, 16:457-467

Published Date: 15 January 2021

Liver-Targeting and pH-Sensitive Sulfated Hyaluronic Acid Mixed Micelles for Hepatoma Therapy

Li Z, Tian G, Jiang H, Pan R, Lian B, Wang M, Gao Z, Zhang B, Wu J

International Journal of Nanomedicine 2019, 14:9437-9452

Published Date: 2 December 2019

Liver-targeted liposomes for codelivery of curcumin and combretastatin A4 phosphate: preparation, characterization, and antitumor effects

Jiang H, Li ZP, Tian GX, Pan RY, Xu CM, Zhang B, Wu JL

International Journal of Nanomedicine 2019, 14:1789-1804

Published Date: 8 March 2019

A facile route to form self-carried redox-responsive vorinostat nanodrug for effective solid tumor therapy

Han LQ, Wang TQ, Wu JL, Yin XL, Fang H, Zhang N

International Journal of Nanomedicine 2016, 11:6003-6022

Published Date: 11 November 2016